Department of Emergency Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Department of Emergency Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Shock. 2023 Jul 1;60(1):42-50. doi: 10.1097/SHK.0000000000002151. Epub 2023 Jun 3.
Background: Pulmonary sepsis and abdominal sepsis have pathophysiologically distinct phenotypes. This study aimed to compare their clinical characteristics and predictors of mortality. Methods: In this multicenter retrospective trial, 1,359 adult patients who fulfilled the Sepsis-3 criteria were enrolled and classified into the pulmonary sepsis or abdominal sepsis groups. Plasma presepsin was measured, and the scores of Acute Physiology and Chronic Health Evaluation (APACHE) II, Mortality in Emergency Department Sepsis (MEDS), and Simplified Acute Physiology Score (SAPS) II were calculated at enrollment. Data on 28-day mortality were collected for all patients. Results: Compared with patients with abdominal sepsis (n = 464), patients with pulmonary sepsis (n = 895) had higher 28-day mortality rate, illness severity scores, incidence of shock and acute kidney injury, and hospitalization costs. Lactate level and APACHE II and MEDS scores were independently associated with 28-day mortality in both sepsis types. Independent predictors of 28-day mortality included Pa o2 /F io2 ratio (hazard ratio [HR], 0.998; P < 0.001) and acute kidney injury (HR, 1.312; P = 0.039) in pulmonary sepsis, and SAPS II (HR, 1.037; P = 0.017) in abdominal sepsis. A model that combined APACHE II score, lactate, and MEDS score or SAPS II score had the best area under the receiver operating characteristic curve in predicting mortality in patients with pulmonary sepsis or abdominal sepsis, respectively. Interaction term analysis confirmed the association between 28-day mortality and lactate, APACHE II score, MEDS score, SAPS II score, and shock according to the sepsis subgroups. The mortality of patients with pulmonary sepsis was higher than that of patients with abdominal sepsis among patients without shock (32.9% vs. 8.8%; P < 0.001) but not among patients with shock (63.7 vs. 48.4%; P = 0.118). Conclusions: Patients with pulmonary sepsis had higher 28-day mortality than patients with abdominal sepsis. The study identified sepsis subgroup-specific mortality predictors. Shock had a larger effect on mortality in patients with abdominal sepsis than in those with pulmonary sepsis.
肺部脓毒症和腹腔脓毒症在病理生理学上具有不同的表型。本研究旨在比较它们的临床特征和死亡率预测因素。
在这项多中心回顾性试验中,纳入了 1359 名符合 Sepsis-3 标准的成年患者,并将其分为肺部脓毒症或腹腔脓毒症组。测量血浆 Presepsin 水平,并计算急性生理学和慢性健康评估(APACHE)II 评分、急诊脓毒症死亡率(MEDS)评分和简化急性生理学评分(SAPS)II 评分。所有患者均收集 28 天死亡率数据。
与腹腔脓毒症患者(n=464)相比,肺部脓毒症患者(n=895)的 28 天死亡率、疾病严重程度评分、休克和急性肾损伤的发生率以及住院费用更高。乳酸水平以及 APACHE II 和 MEDS 评分与两种类型的脓毒症 28 天死亡率均独立相关。肺部脓毒症 28 天死亡率的独立预测因素包括 PaO2/FIO2 比值(危险比 [HR],0.998;P<0.001)和急性肾损伤(HR,1.312;P=0.039),而腹腔脓毒症的独立预测因素则是 SAPS II(HR,1.037;P=0.017)。在预测肺部脓毒症或腹腔脓毒症患者死亡率方面,联合 APACHE II 评分、乳酸和 MEDS 评分或 SAPS II 评分的模型具有最佳的受试者工作特征曲线下面积。交互项分析证实了根据脓毒症亚组,28 天死亡率与乳酸、APACHE II 评分、MEDS 评分、SAPS II 评分和休克之间的关系。在无休克的患者中,肺部脓毒症患者的死亡率高于腹腔脓毒症患者(32.9% vs. 8.8%;P<0.001),但在休克的患者中则没有差异(63.7% vs. 48.4%;P=0.118)。
肺部脓毒症患者 28 天死亡率高于腹腔脓毒症患者。本研究确定了脓毒症亚组特异性死亡率预测因素。休克对腹腔脓毒症患者的死亡率影响大于肺部脓毒症患者。